- Home
- BARK vs ADCT Comparison
BARK vs ADCT Comparison
Compare BARK & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- ADCT
- Stock Information
- Founded
- BARK 2011
- ADCT 2011
- Country
- BARK United States
- ADCT Switzerland
- Employees
- BARK N/A
- ADCT N/A
- Industry
- BARK Department/Specialty Retail Stores
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- BARK Consumer Discretionary
- ADCT Health Care
- Exchange
- BARK Nasdaq
- ADCT Nasdaq
- Market Cap
- BARK 308.9M
- ADCT 224.3M
- IPO Year
- BARK N/A
- ADCT 2020
- Fundamental
- Price
- BARK $2.21
- ADCT $1.98
- Analyst Decision
- BARK Buy
- ADCT Strong Buy
- Analyst Count
- BARK 2
- ADCT 5
- Target Price
- BARK $2.20
- ADCT $8.00
- AVG Volume (30 Days)
- BARK 1.3M
- ADCT 1.4M
- Earning Date
- BARK 02-05-2025
- ADCT 11-07-2024
- Dividend Yield
- BARK N/A
- ADCT N/A
- EPS Growth
- BARK N/A
- ADCT N/A
- EPS
- BARK N/A
- ADCT N/A
- Revenue
- BARK $488,881,000.00
- ADCT $70,717,000.00
- Revenue This Year
- BARK $3.23
- ADCT $6.38
- Revenue Next Year
- BARK $10.01
- ADCT $11.73
- P/E Ratio
- BARK N/A
- ADCT N/A
- Revenue Growth
- BARK N/A
- ADCT N/A
- 52 Week Low
- BARK $0.71
- ADCT $1.18
- 52 Week High
- BARK $2.56
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- BARK 64.14
- ADCT 42.00
- Support Level
- BARK $2.27
- ADCT $1.80
- Resistance Level
- BARK $2.39
- ADCT $3.49
- Average True Range (ATR)
- BARK 0.15
- ADCT 0.40
- MACD
- BARK 0.02
- ADCT 0.04
- Stochastic Oscillator
- BARK 60.57
- ADCT 10.65
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.